The gene expression market in Germany is expected to reach a projected revenue of US$ 948.3 million by 2030. A compound annual growth rate of 4.5% is expected of Germany gene expression market from 2023 to 2030.
Catalent Inc, Qiagen NV, Quest Diagnostics Inc, Roche, Illumina Inc, PerkinElmer, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Agilent Technologies, GE HealthCare Technologies Inc Common Stock, Promega, Luminex, Takara Bio Inc, Danaher Corp
Other key industry trends
In terms of revenue, Germany accounted for 4.8% of the global gene expression market in 2022.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, Germany gene expression market is projected to lead the regional market in terms of revenue in 2030.
UK is the fastest growing regional market in Europe and is projected to reach USD 472.7 million by 2030.
Technological advances, along with presence of companies offering tools and services that support gene expression studies, are contributing to the country’s highest revenue share in the region. Key players in the country offer bioinformatics, sequencing, and technology platforms, including PCR cloning kits, expression vectors, HPLC, and others for functional screening and generation of genome and metagenome clone libraries.
Universities and academic institutes offer advanced courses and training for use of bioinformatics tools for genomic studies. This has resulted in a large number of skilled personnel and experts in the country.
In addition, emerging facets of gene expression profiling allows understanding of various diseases at transcriptional levels. It is expected to provide highefficiency treatments by enabling the availability of highly personalized medicines based on an individual’s gene expression patterns.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Gene Expression Market will help companies and investors design strategic landscapes.
Cdna Synthesis & Conversion was the largest segment with a revenue share of 26.97% in 2022.
Horizon Databook has segmented the Germany gene expression market based on sample collection, purification, cdna synthesis & conversion, pcr analysis, data analysis & interpretation covering the revenue growth of each sub-segment from 2018 to 2030.
Technological advances, along with presence of companies offering tools and services that support gene expression studies, are contributing to the country’s highest revenue share in the region. Key players in the country offer bioinformatics, sequencing, and technology platforms, including PCR cloning kits, expression vectors, HPLC, and others for functional screening and generation of genome and metagenome clone libraries.
Universities and academic institutes offer advanced courses and training for use of bioinformatics tools for genomic studies. This has resulted in a large number of skilled personnel and experts in the country.
In addition, emerging facets of gene expression profiling allows understanding of various diseases at transcriptional levels. It is expected to provide highefficiency treatments by enabling the availability of highly personalized medicines based on an individual’s gene expression patterns.
Germany Gene Expression Market Process Outlook (Revenue, USD Million , 2018-2030)
Sample Collection
Purification
cDNA Synthesis & Conversion
PCR Analysis
Data Analysis & Interpretation
Germany Gene Expression Market Product Outlook (Revenue, USD Million , 2018-2030)
Kits & Reagents
DNA Chips
Others
Germany Gene Expression Market Capacity Outlook (Revenue, USD Million , 2018-2030)
Low- to Mid- Plex
High-Plex
Germany Gene Expression Market Application Outlook (Revenue, USD Million , 2018-2030)
Drug Discovery & Development
Clinical Diagnostics
Biotech & Microbiology
Others
Germany Gene Expression Market Technique Outlook (Revenue, USD Million , 2018-2030)
RNA Expression
Promoter Analysis
Protein Expression & Posttranslational Modification Analysis
Reasons to subscribe to gene expression analysis market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of gene expression analysis market databook
Our clientele includes a mix of gene expression analysis market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany gene expression analysis market, including forecasts for subscribers. This country databook contains high-level insights into Germany gene expression analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.